rosiglitazone has been researched along with masoprocol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Amri, EZ; Berge, RK; Fleckner, J; Furstenberger, G; Hallenborg, P; Jørgensen, C; Krieg, P; Kristiansen, K; Madsen, L; Petersen, RK; Pridal, L; Sørensen, MB | 1 |
2 other study(ies) available for rosiglitazone and masoprocol
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Adipocyte differentiation of 3T3-L1 preadipocytes is dependent on lipoxygenase activity during the initial stages of the differentiation process.
Topics: 3T3-L1 Cells; Adipocytes; Adipogenesis; Adipose Tissue, Brown; Adipose Tissue, White; Animals; Arachidonate 12-Lipoxygenase; Arachidonate 15-Lipoxygenase; Dose-Response Relationship, Drug; Flavanones; Ligands; Lipoxygenase; Lipoxygenase Inhibitors; Masoprocol; Mice; PPAR gamma; Rosiglitazone; Thiazolidinediones; Time Factors; Transcriptional Activation | 2003 |